Authored By: Sarah
20 Nov 2023

Human Microbiome Therapeutics Market to Register USD 732.95 Mn revenue growththrough 2023-2027

4D Pharma Plc, ENTEROME SA, and Ferring B.V. will emerge as major human microbiome therapeutics market participants

As per Technavio's Research Analysis, the Human Microbiome Therapeutics Market is likely to register a CAGR of 47.79% with an incremental growth of USD USD 732.95 million  One of the key factors driving the human microbiome therapeutics market growth is the growing prevalence of chronic diseases. The human microbiome therapeutics market report also offers information on several market players, including 4D pharma Plc, ENTEROME SA, Ferring B.V., Johnson and Johnson Inc., Kaleido Biosciences Inc., OptiBiotix Health Plc, PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., and Takeda Pharmaceutical Co. Ltd. among others.

The market can be segmented by application (gastrointestinal disorders, infectious diseases, and others) and geographic (North America, Europe, Asia, and ROW)

human microbiome market size, human microbiome market share, human microbiome market trends,human microbiome market forecast

Snapshot of Human Microbiome Therapeutics Market Analysis

In-depth research of the market's revenue projections, along with a look at the major players, market drivers, and development prospects, are all included in Technavio's latest report. Learn more about the market dynamics and the aspects that our report's in-depth analysis predicts will have the biggest impact on the market under review.

Emerging Opportunities with Key players

  • 4D Pharma Plc - The company offers microbiome therapeutics through a new approach to the treatment of a broad range of diseases, from cancer to asthma and conditions of the CNS.
  • ENTEROME SA - The company offers microbiome therapeutics through tablets such as EM101, EO2401, and more.
  • Ferring B.V. - The company offers ZOMACTON under this segment.
  • Johnson and Johnson Inc. - The company offers human microbiome therapeutics under pharmaceutical products.
  • Kaleido Biosciences Inc.- The company offers human microbiome therapeutics through its broad portfolio of novel product candidates, Microbiome Metabolic Therapies, MMTs.

Techanvio's report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. For more insights and data-backed analysis download our best-selling report on Human Microbiome Therapeutics Market

Human Microbiome Therapeutics Market Highlights of the Report

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive human microbiome therapeutics market growth during the next five years
  • Precise estimation of the human microbiome therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the human microbiome therapeutics market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vore companies
Read News Read Less
Interested in this report?
Get your sample now!